Pronounced enhancement of .NO-dependent antimicrobial action by an .NO-oxidizing agent, imidazolineoxyl N-oxide

The antimicrobial action of .NO against Cryptococcus neoformans was investigated by using imidazolineoxyl N-oxide, which we recently reported removes .NO via oxidation (T. Akaike, M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda, and H. Maeda, Biochemistry 32:827-832, 1993). No appreciable fungicidal activity was observed in neutral .NO solutions. Imidazolineoxyl N-oxide induced or enhanced fungicidal action in neutral or acidic .NO solutions, respectively. Our results provide convincing evidence that .NO is not a microbicidal molecular species.

[1]  H. Maeda,et al.  Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. , 1993, Biochemistry.

[2]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[3]  Y. Henry,et al.  Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. , 1992, The Journal of biological chemistry.

[4]  L. Zhu,et al.  Bactericidal activity of peroxynitrite. , 1992, Archives of biochemistry and biophysics.

[5]  W. Pryor,et al.  Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. , 1992, Chemical research in toxicology.

[6]  H. Maeda,et al.  Bactericidal activity of alkyl peroxyl radicals generated by heme-iron-catalyzed decomposition of organic peroxides. , 1992, Archives of biochemistry and biophysics.

[7]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[8]  K. Rockett,et al.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives , 1991, Infection and immunity.

[9]  J. Alspaugh,et al.  Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis , 1991, Infection and immunity.

[10]  T. Billiar,et al.  Nitric oxide and nitric oxide‐generating compounds inhibit hepatocyte protein synthesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  C. Nathan,et al.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells , 1989, The Journal of experimental medicine.

[12]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[13]  S. Levitz,et al.  Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans , 1988, Infection and immunity.

[14]  J. Drapier,et al.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. , 1986, The Journal of clinical investigation.

[15]  K. Yamamoto,et al.  Induction of SOS functions by nitrogen dioxide in Escherichia coli with different DNA-repair capacities. , 1986, Mutation research.

[16]  Y. Oda,et al.  Induction of umuC gene expression by nitrogen dioxide in Salmonella typhimurium. , 1985, Mutation research.

[17]  J. H. Silliker,et al.  The effect of nitric oxide on bacteria. , 1962, Applied microbiology.

[18]  C. F. Niven,et al.  Factors affecting the bacteriostatic action of sodium nitrite. , 1955, Applied microbiology.

[19]  J. Drapier.  L-arginine-derived nitric oxide and the cell-mediated immune response. 39th Forum in Immunology. , 1991, Research in immunology.

[20]  J. Perfect,et al.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. , 1990, The Journal of clinical investigation.

[21]  L. Ignarro.  Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.